Needlestick Safety Injection Devices: Opportunities Ahead

Published: October 2014


Roots Analysis has announced the addition of “Needlestick Safety Injection Devices, 2014 - 2024” report to their offering. The study offers a comprehensive view of the product portfolio of safety injection devices, their comparative position vis-à-vis other devices and market forecasts for the period 2014 - 2024. Some other important aspects that have been covered include regulatory guidelines, market developments, partnerships and the likely drivers that will influence the industry’s evolution.

Shefali Asija, the principal analyst, said, “Due to the recent surge of regulations and the need for injection safety at healthcare settings, safety injection devices have emerged as one of the key focus areas for device manufacturers. The market is characterized by the presence of around 70 safety injection devices which offer several advantages over traditional drug delivery systems. The use of these devices not only provides optimal protection to the healthcare employees and patients from accidental needlestick injuries but also facilitates the ease of disposal and is known to offer long term economic advantages.”

Asija further stated, “In addition to the existing established device manufacturers, the market has seen the presence of some relatively new players. These start-ups have recently introduced some important safety devices with innovative features. Some of the key highlights from the study are:

  1. The global market for safety syringes is likely to grow at a CAGR of 9.0% during 2014 - 2024; growth rate for retractable syringes will likely be higher than that for non-retractable syringes.
  2. The market is fragmented, with over 40 companies competing at present. Becton Dickinson remains the market leader, followed by Covidien and Smiths Medical. In addition, there are some relatively new players including Unilife and Revolutions Medical which have introduced passive safety devices in the recent past.
  3. Technological advancements and improvement in regulatory standards are some of the key factors that will likely drive the uptake of this market in the years to come.”

The 226 page report also examines the insights gathered from interviews of some emerging stakeholders in the industry. The forecast, over the next ten years, for both retractable and non-retractable safety syringes, has been presented both in terms of volume (number of units) and value (USD billion). It takes into account the likely price variation which will occur as a result of mass adoption and increased competition.

The research includes detailed profiles and a competitive assessment of the product portfolio of several companies including:

  • West Pharmaceuticals
  • Unilife
  • Becton Dickinson
  • Smiths Medical
  • Catalent
  • Terumo Corporation
  • Covidien

In addition, the study also covers the regional manufacturers along with comparison of their product portfolio.

 

Who will benefit from this report?

This research is targeted towards device manufacturers and pharma companies looking for innovative drug delivery devices. In particular, you could benefit if you are an:

  • Investor
  • CXO level decision maker
  • R&D Manager
  • Business Intelligence / Scientific Analyst
  • Licensing / Portfolio Manager
  • Strategy Manager

For additional details, please visit http://www.rootsanalysis.com/reports/market-reports/view_document/needlestick-safety-injection-devices-2014-2024/69.html

 

About Roots Analysis

Roots Analysis is a specialist market research company, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like us to help you with your growing business needs, get in touch at info@rootsanalysis.com

MEDIA CITATIONS

  • We are your partners with no equity

  • We fit in your budget

  • We love what we do

  • Chance to prove ourselves

  • Best in class quality of work

  • Most trusted consulting partner in the industry